Skip to Main Content

Paper Details

Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with <i>EWSR1</i> fusion-positive sarcomas.
JCO Precis Oncol
43
2017
DSRCT, Desmoplastic Small Round Cell Tumors, ES, EWSR1, EWSR1 fusion, EWSR1 fusion-positive sarcomas, EWSR1 fusions, EWSR1 gene fusions, Ewing Sarcoma, Patients, Plasma DNA, STAG2, TP53, cell-free DNA, cfDNA, cfDNA samples, formalin, genomic EWSR1 fusion breakpoints, patient, patients, plasma, plasma cfDNA, sarcomas, tumor
Author NameAffiliation
Jiabin TangMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center New York
Jiabin TangMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center New York
Agnes VialeMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center New York
Michael F BergerMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
  • 1 - 5

Datasets

Release 1.2